Sponsored By: Royal DSM 

Equivocal results in some recent clinical trials have created confusion about the role of omega-3 fatty acids in cardiovascular health. The publication of three large trials (ASCEND, REDUCE-IT and VITAL) between 2018 and 2019 has significantly increased the evaluable body of clinical evidence, and a recent meta-analysis of large supplementation trials has reported that EPA and DHA positively impacted several important cardiovascular outcomes in a dose-response manner. Several authoritative statements have been issued by regulatory agencies and scientific societies prior to this new information. In this session, we will explore the public health implications of these new findings and discuss what needs to be considered as the totality of the evidence is evaluated in terms of the new expanded Dietary Reference Intakes model.

This webinar was originally broadcasted on March 19, 2020.

Learning Objectives

• Summarize consumer views on low-carbohydrate eating patterns and how the market responds to such trends.
• Discuss the latest scientific evidence on how these eating patterns impact health, particularly weight loss and glycemic management.
• Describe practical considerations of low-carb eating patterns including potential benefits and limitations.